img

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Non Alcoholic Steatohepatitis Treatment market is projected to reach US$ 241.2 million in 2029, increasing from US$ 165 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non Alcoholic Steatohepatitis Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non Alcoholic Steatohepatitis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca Plc.
Tobira Therapeutics Inc.
Galmed Pharmaceuticals
Genfit SA
Zydus Cadila
Bristol Myers Squibb
Gilead Science
Conatus Pharmaceuticals Inc.
Novo Nordisk A/S
Immuron Ltd.
Raptor Pharmaceutical Corporation
Inventiva Pharma
NGM Biopharmaceuticals Inc.
Galectin Therapeutics Inc.
Madrigal Pharmaceuticals
Gemphire Therapeutics
Segment by Type
Vitamin E And Pioglitazone
Ocaliva
Elafibranor
Obeticholic Acid

Segment by Application


Hospital Pharmacies
Retail And Specialty Pharmacies

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non Alcoholic Steatohepatitis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Non Alcoholic Steatohepatitis Treatment Market Overview
1.1 Product Overview and Scope of Non Alcoholic Steatohepatitis Treatment
1.2 Non Alcoholic Steatohepatitis Treatment Segment by Type
1.2.1 Global Non Alcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024-2034)
1.2.2 Vitamin E And Pioglitazone
1.2.3 Ocaliva
1.2.4 Elafibranor
1.2.5 Obeticholic Acid
1.3 Non Alcoholic Steatohepatitis Treatment Segment by Application
1.3.1 Global Non Alcoholic Steatohepatitis Treatment Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail And Specialty Pharmacies
1.4 Global Non Alcoholic Steatohepatitis Treatment Market Size Estimates and Forecasts
1.4.1 Global Non Alcoholic Steatohepatitis Treatment Revenue 2018-2029
1.4.2 Global Non Alcoholic Steatohepatitis Treatment Sales 2018-2029
1.4.3 Global Non Alcoholic Steatohepatitis Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non Alcoholic Steatohepatitis Treatment Market Competition by Manufacturers
2.1 Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2018-2024)
2.2 Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Non Alcoholic Steatohepatitis Treatment Average Price by Manufacturers (2018-2024)
2.4 Global Non Alcoholic Steatohepatitis Treatment Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Non Alcoholic Steatohepatitis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non Alcoholic Steatohepatitis Treatment, Product Type & Application
2.7 Non Alcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
2.7.1 Non Alcoholic Steatohepatitis Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non Alcoholic Steatohepatitis Treatment Players Market Share by Revenue
2.7.3 Global Non Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non Alcoholic Steatohepatitis Treatment Retrospective Market Scenario by Region
3.1 Global Non Alcoholic Steatohepatitis Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non Alcoholic Steatohepatitis Treatment Global Non Alcoholic Steatohepatitis Treatment Sales by Region: 2018-2029
3.2.1 Global Non Alcoholic Steatohepatitis Treatment Sales by Region: 2018-2024
3.2.2 Global Non Alcoholic Steatohepatitis Treatment Sales by Region: 2024-2029
3.3 Global Non Alcoholic Steatohepatitis Treatment Global Non Alcoholic Steatohepatitis Treatment Revenue by Region: 2018-2029
3.3.1 Global Non Alcoholic Steatohepatitis Treatment Revenue by Region: 2018-2024
3.3.2 Global Non Alcoholic Steatohepatitis Treatment Revenue by Region: 2024-2029
3.4 North America Non Alcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.4.1 North America Non Alcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2029)
3.4.3 North America Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non Alcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.5.1 Europe Non Alcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2029)
3.5.3 Europe Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non Alcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Non Alcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non Alcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.7.1 Latin America Non Alcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2029)
3.7.3 Latin America Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non Alcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Non Alcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non Alcoholic Steatohepatitis Treatment Sales by Type (2018-2029)
4.1.1 Global Non Alcoholic Steatohepatitis Treatment Sales by Type (2018-2024)
4.1.2 Global Non Alcoholic Steatohepatitis Treatment Sales by Type (2024-2029)
4.1.3 Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2018-2029)
4.2 Global Non Alcoholic Steatohepatitis Treatment Revenue by Type (2018-2029)
4.2.1 Global Non Alcoholic Steatohepatitis Treatment Revenue by Type (2018-2024)
4.2.2 Global Non Alcoholic Steatohepatitis Treatment Revenue by Type (2024-2029)
4.2.3 Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Non Alcoholic Steatohepatitis Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non Alcoholic Steatohepatitis Treatment Sales by Application (2018-2029)
5.1.1 Global Non Alcoholic Steatohepatitis Treatment Sales by Application (2018-2024)
5.1.2 Global Non Alcoholic Steatohepatitis Treatment Sales by Application (2024-2029)
5.1.3 Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2018-2029)
5.2 Global Non Alcoholic Steatohepatitis Treatment Revenue by Application (2018-2029)
5.2.1 Global Non Alcoholic Steatohepatitis Treatment Revenue by Application (2018-2024)
5.2.2 Global Non Alcoholic Steatohepatitis Treatment Revenue by Application (2024-2029)
5.2.3 Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Non Alcoholic Steatohepatitis Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca Plc.
6.1.1 AstraZeneca Plc. Corporation Information
6.1.2 AstraZeneca Plc. Description and Business Overview
6.1.3 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.1.5 AstraZeneca Plc. Recent Developments/Updates
6.2 Tobira Therapeutics Inc.
6.2.1 Tobira Therapeutics Inc. Corporation Information
6.2.2 Tobira Therapeutics Inc. Description and Business Overview
6.2.3 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.2.5 Tobira Therapeutics Inc. Recent Developments/Updates
6.3 Galmed Pharmaceuticals
6.3.1 Galmed Pharmaceuticals Corporation Information
6.3.2 Galmed Pharmaceuticals Description and Business Overview
6.3.3 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.3.5 Galmed Pharmaceuticals Recent Developments/Updates
6.4 Genfit SA
6.4.1 Genfit SA Corporation Information
6.4.2 Genfit SA Description and Business Overview
6.4.3 Genfit SA Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Genfit SA Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.4.5 Genfit SA Recent Developments/Updates
6.5 Zydus Cadila
6.5.1 Zydus Cadila Corporation Information
6.5.2 Zydus Cadila Description and Business Overview
6.5.3 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.5.5 Zydus Cadila Recent Developments/Updates
6.6 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.6.5 Bristol Myers Squibb Recent Developments/Updates
6.7 Gilead Science
6.6.1 Gilead Science Corporation Information
6.6.2 Gilead Science Description and Business Overview
6.6.3 Gilead Science Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Gilead Science Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.7.5 Gilead Science Recent Developments/Updates
6.8 Conatus Pharmaceuticals Inc.
6.8.1 Conatus Pharmaceuticals Inc. Corporation Information
6.8.2 Conatus Pharmaceuticals Inc. Description and Business Overview
6.8.3 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.8.5 Conatus Pharmaceuticals Inc. Recent Developments/Updates
6.9 Novo Nordisk A/S
6.9.1 Novo Nordisk A/S Corporation Information
6.9.2 Novo Nordisk A/S Description and Business Overview
6.9.3 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.9.5 Novo Nordisk A/S Recent Developments/Updates
6.10 Immuron Ltd.
6.10.1 Immuron Ltd. Corporation Information
6.10.2 Immuron Ltd. Description and Business Overview
6.10.3 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.10.5 Immuron Ltd. Recent Developments/Updates
6.11 Raptor Pharmaceutical Corporation
6.11.1 Raptor Pharmaceutical Corporation Corporation Information
6.11.2 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Description and Business Overview
6.11.3 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.11.5 Raptor Pharmaceutical Corporation Recent Developments/Updates
6.12 Inventiva Pharma
6.12.1 Inventiva Pharma Corporation Information
6.12.2 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Description and Business Overview
6.12.3 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.12.5 Inventiva Pharma Recent Developments/Updates
6.13 NGM Biopharmaceuticals Inc.
6.13.1 NGM Biopharmaceuticals Inc. Corporation Information
6.13.2 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Description and Business Overview
6.13.3 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.13.4 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.13.5 NGM Biopharmaceuticals Inc. Recent Developments/Updates
6.14 Galectin Therapeutics Inc.
6.14.1 Galectin Therapeutics Inc. Corporation Information
6.14.2 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Description and Business Overview
6.14.3 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.14.5 Galectin Therapeutics Inc. Recent Developments/Updates
6.15 Madrigal Pharmaceuticals
6.15.1 Madrigal Pharmaceuticals Corporation Information
6.15.2 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Description and Business Overview
6.15.3 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.15.5 Madrigal Pharmaceuticals Recent Developments/Updates
6.16 Gemphire Therapeutics
6.16.1 Gemphire Therapeutics Corporation Information
6.16.2 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Description and Business Overview
6.16.3 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product Portfolio
6.16.5 Gemphire Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non Alcoholic Steatohepatitis Treatment Industry Chain Analysis
7.2 Non Alcoholic Steatohepatitis Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non Alcoholic Steatohepatitis Treatment Production Mode & Process
7.4 Non Alcoholic Steatohepatitis Treatment Sales and Marketing
7.4.1 Non Alcoholic Steatohepatitis Treatment Sales Channels
7.4.2 Non Alcoholic Steatohepatitis Treatment Distributors
7.5 Non Alcoholic Steatohepatitis Treatment Customers
8 Non Alcoholic Steatohepatitis Treatment Market Dynamics
8.1 Non Alcoholic Steatohepatitis Treatment Industry Trends
8.2 Non Alcoholic Steatohepatitis Treatment Market Drivers
8.3 Non Alcoholic Steatohepatitis Treatment Market Challenges
8.4 Non Alcoholic Steatohepatitis Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Non Alcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Non Alcoholic Steatohepatitis Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Non Alcoholic Steatohepatitis Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non Alcoholic Steatohepatitis Treatment Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Non Alcoholic Steatohepatitis Treatment Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Non Alcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Non Alcoholic Steatohepatitis Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Non Alcoholic Steatohepatitis Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Non Alcoholic Steatohepatitis Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non Alcoholic Steatohepatitis Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Non Alcoholic Steatohepatitis Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non Alcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Alcoholic Steatohepatitis Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Non Alcoholic Steatohepatitis Treatment Sales by Region (2018-2024) & (K Units)
Table 18. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2018-2024)
Table 19. Global Non Alcoholic Steatohepatitis Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Non Alcoholic Steatohepatitis Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Region (2018-2024)
Table 23. Global Non Alcoholic Steatohepatitis Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Non Alcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 27. North America Non Alcoholic Steatohepatitis Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Non Alcoholic Steatohepatitis Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Non Alcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 32. Europe Non Alcoholic Steatohepatitis Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Non Alcoholic Steatohepatitis Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Non Alcoholic Steatohepatitis Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Non Alcoholic Steatohepatitis Treatment Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Non Alcoholic Steatohepatitis Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Non Alcoholic Steatohepatitis Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Non Alcoholic Steatohepatitis Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Non Alcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Non Alcoholic Steatohepatitis Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Non Alcoholic Steatohepatitis Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Non Alcoholic Steatohepatitis Treatment Sales (K Units) by Type (2018-2024)
Table 51. Global Non Alcoholic Steatohepatitis Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2018-2024)
Table 53. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Non Alcoholic Steatohepatitis Treatment Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Non Alcoholic Steatohepatitis Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2024)
Table 57. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2018-2024)
Table 59. Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Non Alcoholic Steatohepatitis Treatment Sales (K Units) by Application (2018-2024)
Table 61. Global Non Alcoholic Steatohepatitis Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2018-2024)
Table 63. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Non Alcoholic Steatohepatitis Treatment Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Non Alcoholic Steatohepatitis Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2024)
Table 67. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2018-2024)
Table 69. Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. AstraZeneca Plc. Corporation Information
Table 71. AstraZeneca Plc. Description and Business Overview
Table 72. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product
Table 74. AstraZeneca Plc. Recent Developments/Updates
Table 75. Tobira Therapeutics Inc. Corporation Information
Table 76. Tobira Therapeutics Inc. Description and Business Overview
Table 77. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product
Table 79. Tobira Therapeutics Inc. Recent Developments/Updates
Table 80. Galmed Pharmaceuticals Corporation Information
Table 81. Galmed Pharmaceuticals Description and Business Overview
Table 82. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product
Table 84. Galmed Pharmaceuticals Recent Developments/Updates
Table 85. Genfit SA Corporation Information
Table 86. Genfit SA Description and Business Overview
Table 87. Genfit SA Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Genfit SA Non Alcoholic Steatohepatitis Treatment Product
Table 89. Genfit SA Recent Developments/Updates
Table 90. Zydus Cadila Corporation Information
Table 91. Zydus Cadila Description and Business Overview
Table 92. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product
Table 94. Zydus Cadila Recent Developments/Updates
Table 95. Bristol Myers Squibb Corporation Information
Table 96. Bristol Myers Squibb Description and Business Overview
Table 97. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product
Table 99. Bristol Myers Squibb Recent Developments/Updates
Table 100. Gilead Science Corporation Information
Table 101. Gilead Science Description and Business Overview
Table 102. Gilead Science Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Gilead Science Non Alcoholic Steatohepatitis Treatment Product
Table 104. Gilead Science Recent Developments/Updates
Table 105. Conatus Pharmaceuticals Inc. Corporation Information
Table 106. Conatus Pharmaceuticals Inc. Description and Business Overview
Table 107. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product
Table 109. Conatus Pharmaceuticals Inc. Recent Developments/Updates
Table 110. Novo Nordisk A/S Corporation Information
Table 111. Novo Nordisk A/S Description and Business Overview
Table 112. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product
Table 114. Novo Nordisk A/S Recent Developments/Updates
Table 115. Immuron Ltd. Corporation Information
Table 116. Immuron Ltd. Description and Business Overview
Table 117. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product
Table 119. Immuron Ltd. Recent Developments/Updates
Table 120. Raptor Pharmaceutical Corporation Corporation Information
Table 121. Raptor Pharmaceutical Corporation Description and Business Overview
Table 122. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product
Table 124. Raptor Pharmaceutical Corporation Recent Developments/Updates
Table 125. Inventiva Pharma Corporation Information
Table 126. Inventiva Pharma Description and Business Overview
Table 127. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product
Table 129. Inventiva Pharma Recent Developments/Updates
Table 130. NGM Biopharmaceuticals Inc. Corporation Information
Table 131. NGM Biopharmaceuticals Inc. Description and Business Overview
Table 132. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product
Table 134. NGM Biopharmaceuticals Inc. Recent Developments/Updates
Table 135. Galectin Therapeutics Inc. Corporation Information
Table 136. Galectin Therapeutics Inc. Description and Business Overview
Table 137. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product
Table 139. Galectin Therapeutics Inc. Recent Developments/Updates
Table 140. Madrigal Pharmaceuticals Corporation Information
Table 141. Madrigal Pharmaceuticals Description and Business Overview
Table 142. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product
Table 144. Madrigal Pharmaceuticals Recent Developments/Updates
Table 145. Gemphire Therapeutics Corporation Information
Table 146. Gemphire Therapeutics Description and Business Overview
Table 147. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product
Table 149. Gemphire Therapeutics Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Non Alcoholic Steatohepatitis Treatment Distributors List
Table 153. Non Alcoholic Steatohepatitis Treatment Customers List
Table 154. Non Alcoholic Steatohepatitis Treatment Market Trends
Table 155. Non Alcoholic Steatohepatitis Treatment Market Drivers
Table 156. Non Alcoholic Steatohepatitis Treatment Market Challenges
Table 157. Non Alcoholic Steatohepatitis Treatment Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non Alcoholic Steatohepatitis Treatment
Figure 2. Global Non Alcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Non Alcoholic Steatohepatitis Treatment Market Share by Type in 2022 & 2029
Figure 4. Vitamin E And Pioglitazone Product Picture
Figure 5. Ocaliva Product Picture
Figure 6. Elafibranor Product Picture
Figure 7. Obeticholic Acid Product Picture
Figure 8. Global Non Alcoholic Steatohepatitis Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Non Alcoholic Steatohepatitis Treatment Market Share by Application in 2022 & 2029
Figure 10. Hospital Pharmacies
Figure 11. Retail And Specialty Pharmacies
Figure 12. Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Non Alcoholic Steatohepatitis Treatment Market Size (2018-2029) & (US$ Million)
Figure 14. Global Non Alcoholic Steatohepatitis Treatment Sales (2018-2029) & (K Units)
Figure 15. Global Non Alcoholic Steatohepatitis Treatment Average Price (US$/Unit) & (2018-2029)
Figure 16. Non Alcoholic Steatohepatitis Treatment Report Years Considered
Figure 17. Non Alcoholic Steatohepatitis Treatment Sales Share by Manufacturers in 2022
Figure 18. Global Non Alcoholic Steatohepatitis Treatment Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Non Alcoholic Steatohepatitis Treatment Players: Market Share by Revenue in 2022
Figure 20. Non Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Non Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Non Alcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2029)
Figure 23. North America Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2029)
Figure 24. United States Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Non Alcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2029)
Figure 27. Europe Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2029)
Figure 28. Germany Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Non Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Region (2018-2029)
Figure 35. China Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Non Alcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2029)
Figure 43. Latin America Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Non Alcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Non Alcoholic Steatohepatitis Treatment by Type (2018-2029)
Figure 53. Global Revenue Market Share of Non Alcoholic Steatohepatitis Treatment by Type (2018-2029)
Figure 54. Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Non Alcoholic Steatohepatitis Treatment by Application (2018-2029)
Figure 56. Global Revenue Market Share of Non Alcoholic Steatohepatitis Treatment by Application (2018-2029)
Figure 57. Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2018-2029)
Figure 58. Non Alcoholic Steatohepatitis Treatment Value Chain
Figure 59. Non Alcoholic Steatohepatitis Treatment Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries